@article{ad3fc9fb3fa3430fafd69581f92b840a,
title = "Changing the clinical landscape for treatment of bipolar disorder—To be (cautiously) welcomed",
author = "Sameer Jauhar and Danilo Arnone and Young, {Allan H.}",
note = "Funding Information: AHY reports paid lectures and advisory boards for the following companies with drugs used in affective and related disorders: AstraZeneca (AZ), Eli Lilly, Lundbeck, Sunovion, Servier, LivaNova, and Janssen. No shareholdings in pharmaceutical companies. Lead Investigator for Embolden Study (AZ), BCI Neuroplasticity study and Aripiprazole Mania Study. Investigator initiated studies from AZ, Eli Lilly, Lundbeck, Wyeth, Janssen. SJ has received honorarium for lectures from Sunovian. KCL has received honorariua from Lundbeck for lectures SJ has given. DA has received travel grants from Jansen‐Cilag and Servier and sponsorship from Lundbeck. Funding Information: This paper represents independent research funded by the National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. Funding Information: This paper represents independent research funded by the National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. ",
year = "2020",
month = sep,
day = "1",
doi = "10.1111/bdi.12945",
language = "English",
volume = "22",
pages = "636--637",
journal = "Bipolar Disorders",
issn = "1398-5647",
publisher = "Blackwell Munksgaard",
number = "6",
}